Pak Fah Yeow International Ltd
HKEX:239
Pak Fah Yeow International Ltd
HKEX:239
Price:
2.35
HKD
-1.26%
Market Closed
Market Cap:
HK$732.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pak Fah Yeow International Ltd
HKEX:239
|
HK |
|
Rocket Lab USA Inc
NASDAQ:RKLB
|
US |
|
C
|
Capital Trust Ltd
NSE:CAPTRUST
|
IN |
|
N
|
Newsmax Inc
NYSE:NMAX
|
US |
Relative Value
The Relative Value of one
Pak Fah Yeow International Ltd
stock under the Base Case scenario is
hidden
HKD.
Compared to the current market price of 2.35 HKD,
Pak Fah Yeow International Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Pak Fah Yeow International Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Pak Fah Yeow International Ltd Competitors
Pak Fah Yeow International Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
|
Pak Fah Yeow International Ltd
HKEX:239
|
732.4m HKD | 3.7 | 10.3 | 3.8 | 3.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.2 | 41.7 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.8 | 27.8 | 15.5 | 21.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.5 | 12.7 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.3 | 6.9 | 8.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
